Pulmonary hypertension is associated with worse survival in hypertrophic cardiomyopathy
Open Access
- 27 February 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 17 (6) , 604-610
Abstract
Pulmonary hypertension (PH) is associated with increased mortality in various forms of left-sided heart disease. However, the implications of PH in hypertrophic cardiomyopathy (HCM) have not been elucidated. The objective of this study was to determine the prevalence and prognostic implications of PH in HCM. The study cohort consisted of 1570 (54 ± 15 years; 53% male) adults with HCM followed for a median of 3.3 years. PH [pulmonary artery systolic pressure (PASP) >36 mmHg] was identified in 38% of patients who were older (57 ± 15 vs. 52 ± 15 years, P < 0.0001), more likely to be female (59 vs. 40%, P < 0.0001), and were characterized by a higher prevalence of New York Heart Association (NYHA) class 3 or 4 symptoms (61 vs. 45%, P < 0.0001) and atrial fibrillation (29 vs. 15%, P < 0.0001) vs. those without PH. Only 12% had moderate or severe PH (PASP >50 mmHg). In multivariate Cox regression analyses adjusted for age, sex, NYHA class 3 or 4 symptoms, and atrial fibrillation, PASP was an independent predictor of all-cause mortality in patients with non-obstructive HCM (HR 1.59 per 10 mmHg PASP increase, 95% CI 1.28–1.96, P < 0.0001) and in those with obstructive physiology who did not undergo septal reduction therapy (SRT) (HR 1.15 per 10 mmHg PASP, 95% CI 1.01–1.31, P = 0.035). However, PH was not predictive of outcomes in patients with obstructive HCM who underwent SRT. Over one-third of adults evaluated in our referral HCM clinic demonstrated concomitant PH, and this was associated with increased mortality except in those with obstructive HCM who underwent SRT.Keywords
This publication has 34 references indexed in Scilit:
- 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathyEuropean Heart Journal, 2014
- Pulmonary Pressures and Death in Heart FailureJACC, 2012
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive SummaryCirculation, 2011
- Hypertrophic CardiomyopathyCurrent Problems in Cardiology, 2011
- Pulmonary hypertension with left-sided heart diseaseNature Reviews Cardiology, 2010
- Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: A Multicenter Long-term International StudyEuropean Heart Journal, 2010
- Pulmonary Hypertension in Heart Failure With Preserved Ejection FractionJACC, 2009
- Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract ObstructionCirculation, 2006
- Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implicationsJACC, 2002
- Pulmonary Hypertension Predicts Mortality and Morbidity in Patients with Dilated CardiomyopathyAnnals of Internal Medicine, 1992